| Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH L Zhu, SS Baker, C Gill, W Liu, R Alkhouri, RD Baker, SR Gill Hepatology 57 (2), 601-609, 2013 | 1722 | 2013 |
| Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD NA Jiao, SS Baker, A Chapa-Rodriguez, W Liu, CA Nugent, M Tsompana, ... Gut 67 (10), 1881-1891, 2018 | 515 | 2018 |
| Structural changes in the gut microbiome of constipated patients L Zhu, W Liu, R Alkhouri, RD Baker, JE Bard, EM Quigley, SS Baker Physiological genomics 46 (18), 679-686, 2014 | 352 | 2014 |
| Gut microbiome may contribute to insulin resistance and systemic inflammation in obese rodents: a meta-analysis N Jiao, SS Baker, CA Nugent, M Tsompana, L Cai, Y Wang, MJ Buck, ... Physiological genomics 50 (4), 244-254, 2018 | 235 | 2018 |
| Role of alcohol metabolism in non-alcoholic steatohepatitis SS Baker, RD Baker, W Liu, NJ Nowak, L Zhu PloS one 5 (3), e9570, 2010 | 216 | 2010 |
| Pathogenesis of nonalcoholic steatohepatitis W Liu, RD Baker, T Bhatia, L Zhu, SS Baker Cellular and Molecular Life Sciences 73, 1969-1987, 2016 | 211 | 2016 |
| Enteric involvement in hospitalised patients with COVID-19 outside Wuhan Y Wan, J Li, L Shen, Y Zou, L Hou, L Zhu, HS Faden, Z Tang, M Shi, ... The lancet Gastroenterology & hepatology 5 (6), 534-535, 2020 | 189 | 2020 |
| Gut microbiome and nonalcoholic fatty liver diseases L Zhu, RD Baker, SS Baker Pediatric research 77 (1), 245-251, 2015 | 162 | 2015 |
| Upregulation of hemoglobin expression by oxidative stress in hepatocytes and its implication in nonalcoholic steatohepatitis W Liu, SS Baker, RD Baker, NJ Nowak, L Zhu PloS one 6 (9), e24363, 2011 | 153 | 2011 |
| Identification of microbial markers across populations in early detection of colorectal cancer Y Wu, N Jiao, R Zhu, Y Zhang, D Wu, AJ Wang, S Fang, L Tao, Y Li, ... Nature communications 12 (1), 3063, 2021 | 149 | 2021 |
| In children with nonalcoholic fatty liver disease, cysteamine bitartrate delayed release improves liver enzymes but does not reduce disease activity scores JB Schwimmer, JE Lavine, LA Wilson, BA Neuschwander-Tetri, ... Gastroenterology 151 (6), 1141-1154. e9, 2016 | 134 | 2016 |
| Gastrointestinal sequelae 90 days after discharge for COVID-19 J Weng, Y Li, J Li, L Shen, L Zhu, Y Liang, X Lin, N Jiao, S Cheng, ... The lancet Gastroenterology & hepatology 6 (5), 344-346, 2021 | 119 | 2021 |
| Antioxidant mechanisms in nonalcoholic fatty liver disease W Liu, SS Baker, R D Baker, L Zhu Current drug targets 16 (12), 1301-1314, 2015 | 117 | 2015 |
| Potassium channels: structures, diseases, and modulators C Tian, R Zhu, L Zhu, T Qiu, Z Cao, T Kang Chemical biology & drug design 83 (1), 1-26, 2014 | 116 | 2014 |
| Effect of dietary advanced glycation end products on mouse liver R Patel, SS Baker, W Liu, S Desai, R Alkhouri, R Kozielski, L Mastrandrea, ... PloS one 7 (4), e35143, 2012 | 114 | 2012 |
| Low and high birth weights are risk factors for nonalcoholic fatty liver disease in children KP Newton, HS Feldman, CD Chambers, L Wilson, C Behling, JM Clark, ... The Journal of pediatrics 187, 141-146. e1, 2017 | 110 | 2017 |
| Saturated long-chain fatty acid-producing bacteria contribute to enhanced colonic motility in rats L Zhao, Y Huang, L Lu, W Yang, T Huang, Z Lin, C Lin, H Kwan, ... Microbiome 6, 1-16, 2018 | 106 | 2018 |
| Multi-kingdom microbiota analyses identify bacterial–fungal interactions and biomarkers of colorectal cancer across cohorts NN Liu, N Jiao, JC Tan, Z Wang, D Wu, AJ Wang, J Chen, L Tao, C Zhou, ... Nature Microbiology 7 (2), 238-250, 2022 | 102 | 2022 |
| Drugs and targets in fibrosis X Li, L Zhu, B Wang, M Yuan, R Zhu Frontiers in pharmacology 8, 306391, 2017 | 98 | 2017 |
| High turnover of ezrin T567 phosphorylation: conformation, activity, and cellular function L Zhu, R Zhou, S Mettler, T Wu, A Abbas, J Delaney, JG Forte American Journal of Physiology-Cell Physiology 293 (3), C874-C884, 2007 | 91 | 2007 |
